Cargando…
Combination Drug Therapy for the Management of Alzheimer’s Disease
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Even though the number of AD patients is rapidly growing, there is no effective treatment for this neurodegenerative disorder. At present, implementation of effective treatment approaches for AD is vital to meet clinical needs. In...
Autores principales: | Kabir, Md. Tanvir, Uddin, Md. Sahab, Mamun, Abdullah Al, Jeandet, Philippe, Aleya, Lotfi, Mansouri, Rasha A., Ashraf, Ghulam Md, Mathew, Bijo, Bin-Jumah, May N., Abdel-Daim, Mohamed M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246721/ https://www.ncbi.nlm.nih.gov/pubmed/32380758 http://dx.doi.org/10.3390/ijms21093272 |
Ejemplares similares
-
Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
por: Uddin, Md. Sahab, et al.
Publicado: (2020) -
Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020) -
nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics
por: Kabir, Md. Tanvir, et al.
Publicado: (2020)